Standard Glass Lining Technology
CLOSEDIPO Date: 6 Jan - 8 Jan 2025
Listing Date: 13 Jan 2025
Price Range
₹133 to ₹140 per share
Issue Size
410 Cr
Min Investment
₹14,231
Lot Size
107 Shares
Schedule of Standard Glass Lining Technology
Issue open date
6 Jan 2025
Issue close date
8 Jan 2025
UPI mandate deadline
8 Jan 2025 (5 PM)
Allotment finalization
9 Jan 2025
Share credit
10 Jan 2025
Listing date
13 Jan 2025
Mandate end date
23 Jan 2025
Issue size
| Funds Raised in the IPO | Amount |
|---|---|
| Overall | 410 Cr |
| Fresh Issue | 210 Cr |
| Offer for Sale | 200 Cr |
Allotment DetailsNew
| Allotment Timeline | Details |
|---|---|
| Allotment Date | 9 Jan 2025 |
| Allotment Link | {Link} |
Grey Market PremiumNew
Grey Market Premium (GMP) is the premium at which the shares are traded in the grey market. It gives a fair idea about the listing price of the IPO shares. The GMP can be positive or negative based on the demand and supply of the shares in the grey market.
| Date | Ipo Price | GMP | Estimated Listing Price |
|---|---|---|---|
| 13 Jan 2025 | ₹140 | ₹50 | ₹190 (35.71%) |
| 11 Jan 2025 | ₹140 | ₹48 | ₹188 (34.29%) |
| 10 Jan 2025 | ₹140 | ₹62 | ₹202 (44.29%) |
| 9 Jan 2025 | ₹140 | ₹78 | ₹218 (55.71%) |
| 8 Jan 2025 | ₹140 | ₹91 | ₹231 (65%) |
| 7 Jan 2025 | ₹140 | ₹96 | ₹236 (68.57%) |
| 6 Jan 2025 | ₹140 | ₹92 | ₹232 (66%) |
| 4 Jan 2025 | ₹140 | ₹97 | ₹237 (69%) |
Performance Standard Glass Lining Technology
| Issue Price | Listing Gain | Current Market Price | P/L |
|---|---|---|---|
| ₹133 to ₹140 per share | ₹ 175 (22.86%) | ₹ 136.11 | -2.78% |
About Standard Glass Lining Technology
Incorporated in September 2012, Standard Glass Lining Technology Limited manufactures engineering equipment for the pharmaceutical and chemical sectors. The company provides turnkey solutions, including design, engineering, manufacturing, assembly, installation, and standard operating procedures. Its product portfolio includes Reaction Systems, Storage, Separation and Drying Systems, and Plant Engineering. The company operates eight manufacturing units in Hyderabad and has sales offices in various locations across India. Notable clients include Aurobindo Pharma, Cadila Pharmaceuticals, and Laurus Labs.
| Founded in | 2012 |
| Managing director | Mr. Nageswara Rao Kandula |
| Parent organization | Standard Glass Lining Technology Ltd |
Financial Overview
Strengths
- Top five specialized engineering equipment manufacturers for India’s pharmaceutical and chemical sectors.
- Leading manufacturer of glass-lined, stainless steel, and nickel alloy-based equipment in India.
- Custom solutions for pharmaceutical, chemical, food, and beverage industries.
- Supplied over 11,000 products in the last decade, meeting diverse sector needs.
- In-house manufacturing of stainless steel glass-lined reactors, up to 10KL capacity.
- Active partnerships with HHV Pumps and GL Hakko to strengthen product offerings and market position.
- Equipped with cutting-edge CNC plasma, laser cutting, and welding systems.
Risks
- The company has guaranteed subsidiary loans, and defaults may incur costs that impact profitability.
- Heavy dependence on pharmaceutical and chemical sectors.
- Risks from under-utilization of manufacturing capacity.
- Vulnerability to delays or defaults in customer payments.
- Exposure to raw material cost fluctuations.
- Limited ability to pass on raw material cost increases.
- Dependence on Telangana facilities, subject to risks from disasters and political changes.
Subscription Figures
| Category | Subscription (No. of times) |
|---|---|
| Qualified Institutional Buyers (QIBs) | 327 |
| Non-Institutional Investors (NIIs) | 275 |
| Retail Individual Investors (RIIs) | 65 |
| Employee | N/A |
| Total | 185 |